Oladipupo Olalere
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Oladipupo Olalere has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Katie Crabb
University of Birmingham
2 shared publications - Min-Dee Koh
University of Birmingham
2 shared publications - Shakila Thangaratinam
NIHR Applied Research Collaborative Northwest Coast, University of Liverpool
2 shared publications Amanda Wood
Affiliation Murdoch Children’s Research Institute, Melbourne, Victoria, Australia
1 shared publication- Amie Wilson
Affiliation Liverpool School of Tropical Medicine, Liverpool, United Kingdom
1 shared publication - Annalise Weckesser
Birmingham City University, UK
1 shared publication
Latest Publications
- Open Access
- 23 September 2026
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (9) , e1004887
The effect of lifestyle interventions in women with polyendocrine metabolic ovarian syndrome: A systematic review and meta-analysis
Background: Lifestyle interventions are recommended as first-line treatment in polyendocrine metabolic ovarian syndrome (PMOS), but their effectiveness across various outcomes remains unclear. In this systematic review, we evaluate the effectiveness of lifestyle interventions on reproductive, anthropometric, and metabolic outcomes. Methods and findings: We searched Medline, EMBASE, All EBM, PsycInfo, and CINAHL to June 2026 for studies examining lifestyle intervention compared with minimal or no treatment (usual care) in PMOS. Meta-analyses were conducted using random-effects model to estimate pooled odd ratios (OR) with 95% confidence intervals (CI). We conducted subgroup analyses to evaluate differences by intervention type and duration, and by baseline body mass index (BMI). A total of 34 studies (1,871 participants) were included from the retrieved 1,798 publications. Women who participated in lifestyle interventions were more likely to achieve regular menstrual cycles OR 4.03 (95% CI [1.16, 14.05] I 2 = 73%, 5 studies, 237 women), and have reduced waist circumference mean difference (MD) −2.38 (95% CI [−4.68, −0.08] I 2 = 90%, 18 studies, 915 women), fasting glucose MD −0.13 (95% CI [−0.25, −0.02] I 2 = 86%, 22 studies, 1,045 women) and fasting insulin MD −6.08 (95% CI [−9.86, −2.30] I 2 = 71%, 18 studies, 824 women) compared to women who had minimal or no treatment. Subgroup analyses showed that diet interventions had greater effect on reducing fasting glucose levels while exercise was most effective at reducing waist circumference and fasting insulin. In women with PMOS who were overweight or obese, lifestyle interventions led to greater reduction in weight, waist/hip ratio, fasting glucose, fasting insulin, total testosterone, total cholesterol, and low-density lipoprotein. The main limitation of this review is the high between-study heterogeneity in pooled estimates across many of the outcomes. Conclusion: Our review found that lifestyle interventions were associated with improved menstrual regularity and metabolic outcomes in women with PMOS, suggesting complementary benefits as no single intervention showed overall superiority. These findings support international recommendations, which endorse lifestyle interventions as first-line treatment, tailored to individual needs.
- 23 September 2026
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (9) , e1004887
Open AccessThe effect of lifestyle interventions in women with polyendocrine metabolic ovarian syndrome: A systematic review and meta-analysis
Background: Lifestyle interventions are recommended as first-line treatment in polyendocrine metabolic ovarian syndrome (PMOS), but their effectiveness across various outcomes remains unclear. In this systematic review, we evaluate the effectiveness of lifestyle interventions on reproductive, anthropometric, and metabolic outcomes. Methods and findings: We searched Medline, EMBASE, All EBM, PsycInfo, and CINAHL to June 2026 for studies examining lifestyle intervention compared with minimal or no treatment (usual care) in PMOS. Meta-analyses were conducted using random-effects model to estimate pooled odd ratios (OR) with 95% confidence intervals (CI). We conducted subgroup analyses to evaluate differences by intervention type and duration, and by baseline body mass index (BMI). A total of 34 studies (1,871 participants) were included from the retrieved 1,798 publications. Women who participated in lifestyle interventions were more likely to achieve regular menstrual cycles OR 4.03 (95% CI [1.16, 14.05] I 2 = 73%, 5 studies, 237 women), and have reduced waist circumference mean difference (MD) −2.38 (95% CI [−4.68, −0.08] I 2 = 90%, 18 studies, 915 women), fasting glucose MD −0.13 (95% CI [−0.25, −0.02] I 2 = 86%, 22 studies, 1,045 women) and fasting insulin MD −6.08 (95% CI [−9.86, −2.30] I 2 = 71%, 18 studies, 824 women) compared to women who had minimal or no treatment. Subgroup analyses showed that diet interventions had greater effect on reducing fasting glucose levels while exercise was most effective at reducing waist circumference and fasting insulin. In women with PMOS who were overweight or obese, lifestyle interventions led to greater reduction in weight, waist/hip ratio, fasting glucose, fasting insulin, total testosterone, total cholesterol, and low-density lipoprotein. The main limitation of this review is the high between-study heterogeneity in pooled estimates across many of the outcomes. Conclusion: Our review found that lifestyle interventions were associated with improved menstrual regularity and metabolic outcomes in women with PMOS, suggesting complementary benefits as no single intervention showed overall superiority. These findings support international recommendations, which endorse lifestyle interventions as first-line treatment, tailored to individual needs.
- Open Access
- 31 October 2025
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 22 (10) , e1004580
Associations between epileptic seizures in pregnancy and adverse pregnancy outcomes: A systematic review and meta-analysis
Background: Epileptic seizures during pregnancy may increase the risk of adverse pregnancy outcomes. Socioeconomic disparities in epilepsy incidence may extend to seizure control. We conducted a systematic review and meta-analysis to assess the association between epileptic seizures during pregnancy and adverse pregnancy outcomes. We also evaluated the association between socioeconomic and individual-level factors and seizure occurrence. Methods and findings: We searched MEDLINE, Embase, CINAHL, and PsycINFO databases from inception to May 2025 for observational studies on pregnant women with epileptic seizures. We compared maternal and foetal outcomes in pregnant women with and without seizures and assessed the association between seizure occurrence and socioeconomic or individual-level factors. We used the Newcastle–Ottawa Scale to assess the risk of bias of included studies. Meta-analyses using random effects model were performed to estimate pooled odds ratios (ORs) with 95% confidence intervals (CIs). From 13,381 identified publications, 25 studies (24,596 pregnancies) are included in this analysis. In pregnant women with epilepsy, women with seizures compared to those without had increased odds of caesarean birth (OR 1.62, 95% CI 1.14 to 2.30, p = 0.007), peripartum depression (OR 2.20, 95% CI 1.04 to 4.65, p = 0.04), and small for gestational age baby (OR 1.32, 95% CI 1.03 to 1.69, p = 0.03). The odds of preterm birth (OR 1.66, 95% CI 1.29 to 2.15, p < 0.001), low birthweight (OR 1.47, 95% CI 1.12 to 1.93, p = 0.006), and small for gestational age baby (OR 1.44, 95% CI 1.19 to 1.74, p < 0.001) were higher in women with seizures compared to women without epilepsy. The risk of seizures was greater in pregnant women with epilepsy with low income compared to those with higher income (OR 1.57, 95% CI 1.22 to 2.02, p < 0.001), and in women with focal epilepsy compared to those with generalised epilepsy (OR 1.84, 95% CI 1.54 to 2.20, p < 0.001). The number of studies for some outcomes was small, limiting subgroup analyses and detection of heterogeneity. Conclusion: Epileptic seizures are associated with increased risks of adverse maternal and foetal outcomes. Risk assessment to identify women with epilepsy at highest risk of seizures is needed to optimise care.
- 31 October 2025
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 22 (10) , e1004580
Open AccessAssociations between epileptic seizures in pregnancy and adverse pregnancy outcomes: A systematic review and meta-analysis
Background: Epileptic seizures during pregnancy may increase the risk of adverse pregnancy outcomes. Socioeconomic disparities in epilepsy incidence may extend to seizure control. We conducted a systematic review and meta-analysis to assess the association between epileptic seizures during pregnancy and adverse pregnancy outcomes. We also evaluated the association between socioeconomic and individual-level factors and seizure occurrence. Methods and findings: We searched MEDLINE, Embase, CINAHL, and PsycINFO databases from inception to May 2025 for observational studies on pregnant women with epileptic seizures. We compared maternal and foetal outcomes in pregnant women with and without seizures and assessed the association between seizure occurrence and socioeconomic or individual-level factors. We used the Newcastle–Ottawa Scale to assess the risk of bias of included studies. Meta-analyses using random effects model were performed to estimate pooled odds ratios (ORs) with 95% confidence intervals (CIs). From 13,381 identified publications, 25 studies (24,596 pregnancies) are included in this analysis. In pregnant women with epilepsy, women with seizures compared to those without had increased odds of caesarean birth (OR 1.62, 95% CI 1.14 to 2.30, p = 0.007), peripartum depression (OR 2.20, 95% CI 1.04 to 4.65, p = 0.04), and small for gestational age baby (OR 1.32, 95% CI 1.03 to 1.69, p = 0.03). The odds of preterm birth (OR 1.66, 95% CI 1.29 to 2.15, p < 0.001), low birthweight (OR 1.47, 95% CI 1.12 to 1.93, p = 0.006), and small for gestational age baby (OR 1.44, 95% CI 1.19 to 1.74, p < 0.001) were higher in women with seizures compared to women without epilepsy. The risk of seizures was greater in pregnant women with epilepsy with low income compared to those with higher income (OR 1.57, 95% CI 1.22 to 2.02, p < 0.001), and in women with focal epilepsy compared to those with generalised epilepsy (OR 1.84, 95% CI 1.54 to 2.20, p < 0.001). The number of studies for some outcomes was small, limiting subgroup analyses and detection of heterogeneity. Conclusion: Epileptic seizures are associated with increased risks of adverse maternal and foetal outcomes. Risk assessment to identify women with epilepsy at highest risk of seizures is needed to optimise care.